McKesson Corporation (NYSE: MCK), a diversified healthcare service company that operates in partnership with biopharma companies and care providers, has published its updated long-term financial targets.
- The management has raised and narrowed its FY26 adjusted earnings per share guidance range to $38.05 to $38.55 from the previous range of $37.10 to $37.90
- It has increased its long-term adjusted earnings per share growth target to 13% to 16% from the prior range of 12% to 14%
- McKesson continues to strengthen its portfolio of differentiated assets and capabilities, advancing health outcomes for all
- The company said it is well-positioned to capture long-term growth opportunities through disciplined execution of its strategic priorities and sustained operational momentum
- The long-term adjusted operating profit growth forecast for the North American Pharmaceutical business segment is 5% to 8%
- Oncology & Multispecialty operating profit, on an adjusted basis, is expected to grow 13% to 16% in the long term
- The company expects long-term adjusted operating profit for the Prescription Technology Solutions division to grow 10% to 13%
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Omnichannel push, margin dynamics in focus as Walmart gears up for Q3 earnings
Walmart Inc. (NYSE: WMT) entered the second half of FY26 navigating a challenging retail landscape marked by tariff-related cost pressure and cautious consumer behavior. At the same time, the company
AMAT Earnings: Applied Materials Q4 adjusted profit drops on lower revenues
Semiconductor equipment maker Applied Materials, Inc. (NASDAQ: AMAT) on Thursday reported a decrease in adjusted earnings for the fourth quarter of fiscal 2025. Adjusted earnings declined to $2.17 per share
Disney’s (DIS) streaming business continues its momentum in Q4 2025
Shares of The Walt Disney Company (NYSE: DIS) fell 9% on Thursday after the company delivered mixed results for the fourth quarter of 2025. While earnings beat expectations, revenues fell
